Cicileus derradji sp. nov., a new species from southern Algeria (Scorpiones: Buthidae)

Posted by
  Cicileus derradji sp. nov., a new species from southern Algeria (Scorpiones: Buthidae) Abstract A new scorpion species, Cicileus derradji sp. nov., is described from Tin Zaouatine District, In Guezzam Province, southern Algeria. The description is based on an adult male holotype, an adult female paratype and a juvenile specimen, and is supported by detailed morphological analyses, including colouration, morphometrics, carination patterns and trichobothrial arrangement. This discovery extends the known distribution of the genus Cicileus approximately 500 km southwestward within Algeria. With the addition of this species, the number of recognised species in the genus increases to six. The new species is compared with all previously known species of Cicileus , and detailed colour photographs, including images taken under ultraviolet illumination, are provided. Derradj, L., Aydın Yağmur, E., Benali, N., & Bikada, M. (2026). Cicileus derradji sp. nov., a new species from south...

A Novel Equine F[abʹ]2 Veterinary Antivenom for North American Viperid Snake Envenomation Demonstrates Efficacy by Rapid Serum Venom Removal and Improvement in Snakebite Severity Score

Posted by

 


A Novel Equine F[abʹ]2 Veterinary Antivenom for North American Viperid Snake Envenomation Demonstrates Efficacy by Rapid Serum Venom Removal and Improvement in Snakebite Severity Score

ABSTRACT

Objective

To assess the efficacy of a new equine F[abʹ]2 antivenom (US Department of Agriculture code 6101.05) in removing serum venom and lowering the snakebite severity score (SSS) in animals suffering from naturally occurring viperid envenomation.

Design

Retrospective study, April 2020 to October 2021.

Setting

Veterinary hospitals across four North American regions.

Animals

Twenty-two dogs, one cat, and one horse.

Interventions

All patients received the new antivenom intravenously and were assessed for clinical response. Most dogs required one vial for clinical control of signs.

Measurements and Main Results

Among the dogs and cats with detectable initial serum venom, 94.4% showed a strong response to antivenom administration, with a reduction in serum venom ranging from 94% to >99% at 2 h. Animals that experienced a 90% reduction of serum venom within 2 h greatly exceeded the 0% expected of an ineffective antivenom. The canine and feline SSS improved relative to the initial SSS at 2, 6, and 12 h in 57.9%, 77.8%, and 90.9% of cases, respectively. A favorable reduction in SSS was also appreciated in the single horse in the study.

Conclusions

In the canine, feline, and equine cases of North American viperid envenomation studied, antivenom 6101.05 adequately removed serum venom and lowered the SSS.


Carotenuto, S. E., Broussard, G., Fox, G. A., & Hayes, W. K. A Novel Equine F[abʹ]2 Veterinary Antivenom for North American Viperid Snake Envenomation Demonstrates Efficacy by Rapid Serum Venom Removal and Improvement in Snakebite Severity Score. Journal of Veterinary Emergency and Critical Care. https://doi.org/10.1111/vec.70082